TD Asset Management
TXMD icon

TD Asset Management’s TherapeuticsMD TXMD Stock Holding History

TD Asset Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,581
Closed -$329K – 1555
2021
Q2 		$329K Sell
6,581
-2,100
-24% -$127K ﹤0.01% 1436
2021
Q1 		$582K Hold
8,681
– – ﹤0.01% 1374
2020
Q4 		$525K Buy
8,681
+532
+7% +$36.3K ﹤0.01% 1324
2020
Q3 		$644K Hold
8,149
– – ﹤0.01% 1188
2020
Q2 		$509K Buy
8,149
+550
+7% +$32K ﹤0.01% 1210
2020
Q1 		$403K Hold
7,599
– – ﹤0.01% 1216
2019
Q4 		$920K Buy
7,599
+1,532
+25% +$220K ﹤0.01% 1114
2019
Q3 		$1.1M Sell
6,067
-600
-9% -$84.6K ﹤0.01% 1036
2019
Q2 		$867K Sell
6,667
-354
-5% -$63.5K ﹤0.01% 1076
2019
Q1 		$1.71M Sell
7,021
-428
-6% -$113K ﹤0.01% 934
2018
Q4 		$1.42M Sell
7,449
-2,714
-27% -$662K ﹤0.01% 992
2018
Q3 		$3.33M Buy
10,163
+1,611
+19% +$494K ﹤0.01% 856
2018
Q2 		$2.67M Buy
8,552
+1,694
+25% +$517K ﹤0.01% 882
2018
Q1 		$1.67M Buy
6,858
+324
+5% +$90.9K ﹤0.01% 928
2017
Q4 		$1.97M Buy
6,534
+605
+10% +$168K ﹤0.01% 889
2017
Q3 		$1.57M Sell
5,929
-2,626
-31% -$759K ﹤0.01% 932
2017
Q2 		$2.25M Sell
8,555
-2,403
-22% -$602K ﹤0.01% 848
2017
Q1 		$3.94M Buy
10,958
+444
+4% +$137K 0.01% 742
2016
Q4 		$3.03M Sell
10,514
-512
-5% -$159K 0.01% 776
2016
Q3 		$3.75M Buy
11,026
+368
+3% +$134K 0.01% 758
2016
Q2 		$4.53M Buy
10,658
+32
+0.3% +$13.2K 0.01% 708
2016
Q1 		$3.4M Buy
10,626
+5,116
+93% +$1.75M 0.01% 756
2015
Q4 		$2.86M Buy
5,510
+1,070
+24% +$395K 0.01% 778
2015
Q3 		$1.3M Buy
4,440
+1,146
+35% +$407K ﹤0.01% 880
2015
Q2 		$1.29M Buy
3,294
+108
+3% +$38.1K ﹤0.01% 919
2015
Q1 		$964K Buy
+3,186
New +$778K ﹤0.01% 953

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TD Asset Management's TXMD Position: Q3 2021 in Review

TD Asset Management sold out of TherapeuticsMD (TXMD) in Q3 2021, closing a stake of 6,581 shares — an estimated $329K sold.

TD Asset Management first reported a position in TXMD in Q1 2015 and held it in 26 quarters. The position peaked at $4.53M in Q2 2016. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

  • TD Asset Management reported no remaining TherapeuticsMD position as of Q3 2021 after selling out during the quarter.
  • TD Asset Management sold 6,581 TherapeuticsMD shares in Q3 2021, an estimated $329K.
  • TD Asset Management first reported a position in TherapeuticsMD in Q1 2015 and held it in 26 quarters.
  • TD Asset Management's TherapeuticsMD position peaked at $4.53M in Q2 2016.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on TD Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.